Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 2, 2010, Pages 459-465

  Li, Tao Sheng ^a   Kubo, Masayuki ^a   Ueda, Kazuhiro ^a   Murakami, Masanori ^a   Mikamo, Akihito ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; VASCULOTROPIN;

ADULT; AGED; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; KIDNEY FAILURE; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STERNOTOMY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74649083695     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.07.053     Document Type: Article

References (24)

1. Li T.S., Murakami M., Kobayashi T., Shirasawa B., Mikamo A., and Hamano K. Long-term efficacy and safety of the intramyocardial implantation of autologous bone marrow cells for the treatment of ischemic heart disease. J Thorac Cardiovasc Surg 134 (2007) 1347-1349
2. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
3. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
4. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
5. Seeger F.H., Tonn T., Krzossok N., Zeiher A.M., and Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28 (2007) 766-772
6. Qin S.L., Li T.S., Kubo M., Ohshima M., Furutani A., and Hamano K. Transient increase of cytokines in the acute ischemic tissue is beneficial to cell-based therapeutic angiogenesis. Circ J 72 (2008) 2075-2080
7. Walter D.H., Haendeler J., Reinhold J., Rochwalsky U., Seeger F., Honold J., et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97 (2005) 1142-1151
8. Li T.S., Furutani A., Takahashi M., Ohshima M., Qin S.L., Kobayashi T., et al. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 290 (2006) H1362-H1369
9. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., Barateau V., Lecomte-Raclet L., Clergue M., et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 164 (2004) 57-66
10. Zhang H., Fazel S., Tian H., Mickle D.A., Weisel R.D., Fujii T., et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 289 (2005) H2089-6
11. Li T.S., Suzuki R., Ueda K., Murata T., and Hamano K. Analysis of the origin and population dynamics of cardiac progenitor cells in a donor heart model. Stem Cells 25 (2007) 911-917
12. Li T.S., Ito H., Hayashi M., Furutani A., Matsuzaki M., and Hamano K. Cellular expression of integrin-beta 1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 65 (2005) 64-72
13. Yu J., deMuinck E.D., Zhuang Z., Drinane M., Kauser K., Rubanyi G.M., et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 102 (2005) 10999-11004
14. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90 (2002) e89-e93
15. Kissel C.K., Lehmann R., Assmus B., Aicher A., Honold J., Fischer-Rasokat U., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 49 (2007) 2341-2349
16. Dimmeler S., and Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102 (2008) 1319-1330
17. Spyridopoulos I., Erben Y., Brummendorf T.H., Haendeler J., Dietz K., Seeger F., et al. Telomere gap between granulocytes and lymphocytes is a determinant for haematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thromb Vasc Biol 28 (2008) 968-974
18. Sorrentino S.A., Bahlmann F.H., Besler C., Müller M., Schulz S., Kirchhoff N., et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116 (2007) 163-173
19. Herbrig K., Pistrosch F., Oelschlaegel U., Wichmann G., Wagner A., Foerster S., et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 44 (2004) 840-849
20. Kondo T., Hayashi M., Takeshita K., Numaguchi Y., Kobayashi K., Iino S., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24 (2004) 1442-1447
21. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
22. Hamamoto H., Gorman III J.H., Ryan L.P., Hinmon R., Martens T.P., Schuster M.D., et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 87 (2009) 794-801
23. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
24. Li T.S., Hamano K., Suzuki K., Ito H., Zempo N., and Matsuzaki M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283 (2002) H468-H473